Case Report of Multidisciplinary Management of Peripartum Cardiomyopathy
Abstract
Peripartum cardiomyopathy (PPCM) is a form of heart failure that occurs during pregnancy or in the postpartum period, characterized by reduced left ventricular systolic function [1]. Peripartum cardiomyopathy is one of the leading causes of maternal mortality and morbidity worldwide.
Aim. To demonstrate, through a clinical case, the importance of early diagnosis, timely risk factor identification, and optimized strategies for treatment, delivery, and postpartum care.
Case Report. Patient B, a 36-year-old woman, was urgently admitted to the hospital on the sixth day postpartum due to progressive symptoms of acute heart failure. Examination confirmed peripartum cardiomyopathy, acute heart failure (Killip III, pulmonary edema), severe mitral regurgitation, left atrial dilation, moderate tricuspid regurgitation, moderate pulmonary hypertension, and massive bilateral pleural effusion. The left ventricular ejection fraction (LVEF) was 36 %, with NYHA Functional Class IV. Bilateral thoracentesis was performed, and acute heart failure therapy was administered in the intensive care unit for five days, leading to clinical improvement and improved laboratory and instrumental findings. The patient received heart failure therapy, including bromocriptine, and was managed by a multidisciplinary team of cardiologists, obstetricians, cardiac surgeons, and intensivists. At discharge, the patient’s condition was stable. Echocardiography revealed reduced mitral regurgitation (from severe to moderate), decreased left atrial size, and an LVEF increase to 40 %. NT-proBNP was 533.2 pg/mL, with other laboratory parameters within normal limits. Long-term outcomes were assessed at 2, 6, and 14 months post-discharge. At 14-month follow-up, complete recovery of myocardial and mitral valve function was observed, with a stable clinical condition.
Conclusions. Peripartum cardiomyopathy remains a serious cause of maternal and perinatal morbidity and mortality. Timely diagnosis and management of this condition are possible only through close collaboration within a multidisciplinary team comprising obstetrician-gynecologists, cardiologists, cardiac surgeons, and anesthesiologist-intensivists. Coordinated actions of these specialists contribute to optimizing the management of pregnancy, delivery, and the postpartum period, as well as improving long-term outcomes for both mother and child.
References
- Davis MB, Arany Z, McNamara DM, Goland S, Elkayam U. Peripartum Cardiomyopathy. Journal of the American College of Cardiology. 2020 Jan;75(2):207–21. https://doi.org/10.1016/j.jacc.2019.11.014
- Banayan JM, Rana S, Mueller A, Tung A, Ramadan H, Zoltan Arany, et al. Cardiogenic shock in pregnancy: Analysis from the National Inpatient Sample. Hypertension in Pregnancy. 2017 Apr 3;36(2):117–23. https://doi.org/10.1080/10641955.2016.1242606
- 1.Sliwa K, Mebazaa A, Hilfiker-Kleiner D, Petrie MC, Maggioni AP, Laroche C, et al. Clinical characteristics of patients from the worldwide registry on peripartum cardiomyopathy (PPCM). European Journal of Heart Failure. 2017 Mar 8;19(9):1131–41. https://doi.org/10.1002/ejhf.780
- Gunderson EP, Croen LA, Chiang V, Yoshida CK, Walton D, Go AS. Epidemiology of peripartum cardiomyopathy: incidence, predictors, and outcomes. Obstet Gynecol. 2011 Sep;118(3):583-91. https://doi.org/10.1097/AOG.0b013e31822ad4d0 .
- Viljoen C, Hoevelmann J, Sliwa K. Peripartum cardiomyopathy: risk factors and predictors of outcome. Curr Opin Cardiol. 2023 May 1;38(3):223-232. https://doi.org/10.1097/HCO.0000000000001037. Epub 2023 Mar 2.
- Arany Z. Peripartum Cardiomyopathy. N Engl J Med. 2024 Jan 11;390(2):154-164. https://doi.org/10.1056/NEJMra2306667 .
- Sigauke FR, Ntsinjana H, Tsabedze N. Peripartum cardiomyopathy: a comprehensive and contemporary review. Heart Fail Rev. 2024 Nov;29(6):1261-1278. https://doi.org/10.1007/s10741-024-10435-5 . Epub 2024 Sep 30.
- Sliwa K, van der Meer P, Viljoen C, Jackson AM, Petrie MC, Mebazaa A, et al. Socio-economic factors determine maternal and neonatal outcomes in women with peripartum cardiomyopathy: A study of the ESC EORP PPCM registry. Int J Cardiol. 2024 Mar 1;398:131596. https://doi.org/10.1016/j.ijcard.2023.131596 .
- McNamara DM, Elkayam U, Alharethi R, Damp J, Hsich E, Ewald G, Modi K, Alexis JD, Ramani GV, Semigran MJ, Haythe J, Markham DW, Marek J, Gorcsan J 3rd, Wu WC, Lin Y, Halder I, Pisarcik J, Cooper LT, Fett JD; IPAC Investigators. Clinical Outcomes for Peripartum Cardiomyopathy in North America: Results of the IPAC Study (Investigations of Pregnancy-Associated Cardiomyopathy). J Am Coll Cardiol. 2015 Aug 25;66(8):905-14. https://doi.org/10.1016/j.jacc.2015.06.1309 .
- Brar SS, Khan SS, Sandhu GK, Jorgensen MB, Parikh N, Hsu JW, Shen AY. Incidence, mortality, and racial differences in peripartum cardiomyopathy. Am J Cardiol. 2007 Jul 15;100(2):302-4. https://doi.org/10.1016/j.amjcard.2007.02.092 . Epub 2007 Jun 6.
- Davydova YuV, Dubro SO, Siromakha SO, et al. Heart diseases in women associated with pregnancy. Perinatology and Pediatric. Ukraine. 2018;4(76):33-7. Available from: https://med-expert.com.ua/journals/ua/zahvorjuvannja-sercja-u-zhinok-asocijovani-z-vagitnistju/
- Jackson AM, Macartney M, Brooksbank K, Brown C, Dawson D, Francis M, Japp A, Lennie V, Leslie SJ, Martin T, Neary P, Venkatasubramanian S, Vickers D, Weir RA, McMurray JJV, Jhund PS, Petrie MC. A 20-year population study of peripartum cardiomyopathy. Eur Heart J. 2023 Dec 21;44(48):5128-5141. https://doi.org/10.1093/eurheartj/ehad626 .
- Arbelo E, Protonotarios A, Gimeno JR, Arbustini E, Barriales-Villa R, Basso C, et al. 2023 ESC Guidelines for the management of cardiomyopathies: Developed by the task force on the management of cardiomyopathies of the European Society of Cardiology (ESC). Eur Heart J. 2023 Oct 1;44(37):3503–26. https://doi.org/10.1093/eurheartj/ehad194 .